Holen Sie sich die Stockscreener-App
1.65
3.12%
0.05
Sana Biotechnology Inc Aktie (SANA) Neueste Nachrichten
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stake in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology stock hits 52-week low at $1.8 amid downturn - Investing.com Canada
Layoff Tracker: Editas Will Cut 60% of Staff - BioSpace
Sana Biotechnology's SWOT analysis: cell therapy stock faces pivotal year ahead - Investing.com Canada
Sana Biotechnology stock hits 52-week low at $2.29 By Investing.com - Investing.com Canada
Sana Biotechnology stock hits 52-week low at $2.29 - Investing.com
Sana: Major Inflection Point For SC291 In 2025 Targeting Lupus - Seeking Alpha
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Bought by Fmr LLC - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc.SANA - PR Newswire
Sana Biotechnology Gets FDA Fast Track Designation for SC291 Cell Therapy - MarketWatch
Sana Biotechnology announces Fast Track designation for SC291 - TipRanks
Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic - The Bakersfield Californian
Sana Biotechnology Announces Fast Track Designation for - GlobeNewswire
Sana Biotechnology (NASDAQ:SANA) Trading 9.8% HigherStill a Buy? - MarketBeat
Sana Biotechnology's (SANA) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Sana Biotechnology to Present at December 2024 Investor Conferences - The Manila Times
Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies - Quantisnow
Sana Biotechnology: The Story Becomes Murkier (NASDAQ:SANA) - Seeking Alpha
Sana Biotechnology (NASDAQ:SANA) Sets New 12-Month LowShould You Sell? - MarketBeat
10 Stocks Jeff Bezos Is Buying | Investing - U.S News & World Report Money
Sana Biotechnology's SWOT analysis: stock outlook amid strategic pivot - Investing.com India
Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio - Quantisnow
Sana Biotechnology, Inc. (NASDAQ:SANA) Holdings Lowered by Baillie Gifford & Co. - MarketBeat
Sana Biotechnology stock hits 52-week low at $2.75 By Investing.com - Investing.com Australia
FMR LLC's Strategic Acquisition of Sana Biotechnology Inc Shares - GuruFocus.com
Sana Biotechnology stock hits 52-week low at $2.75 - Investing.com India
Sana Biotech sustains stock target with Buy rating on Q3 earnings - Investing.com Nigeria
Analyst keeps Buy on Sana Biotechnology, adjusts outlook as blood cancer competition rises - Investing.com Canada
Sana Biotechnology's SWOT analysis: stock outlook amid strategic pivot By Investing.com - Investing.com Nigeria
Sana Biotechnology (NASDAQ:SANA) Hits New 1-Year LowWhat's Next? - MarketBeat
Sana Biotechnology Inc Still Hasn’t Convinced Analysts? - Stocks Register
HC Wainwright Reaffirms "Buy" Rating for Sana Biotechnology (NASDAQ:SANA) - MarketBeat
Sana Biotechnology downgraded to Market Perform from Outperform at JMP Securities - MSN
Sana Biotechnology, Inc. Reports Q3 2024 Financial Results - TipRanks
Sana: Q3 Earnings Snapshot - The Washington Post
Sana Biotechnology Inc. (SANA) Quarterly 10-Q Report - Quartzy
Earnings Flash (SANA) SANA BIOTECHNOLOGY Reports Q3 Loss $-0.27 Per Share - Marketscreener.com
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):